Abstract:Lipopolysaccharide (LPS) stimulation of endothelial cells induces the expression of intercellular adhesion molecule-1 (ICAM-1), a critical adhesion molecule involved in the adhesive interaction between leukocytes and endothelial cells in shock and inflammation. Although there is little literature about role of p38 mitogen-activated protein kinase (MAPK) in ICAM-1 protein expression of LPS-induced endothelial cells, it is still not defined whether gene transcription is regulated by p38 MAPK in ICAM-1 expression of LPS-induced endothelial cells. In this study, the potential role of p38 MAPK in ICAM-1 expression of LPS-induced endothelial cells was studied in vitro and in vivo. In vitro studies, the results showed that compared with basic expression of ICAM-1 protein on cultured human umbilical vein endothelial cells (HUVECs), the ICAM-1 expression was increased initially at 2 h after LPS stimulation, reached peak value at 24 h, and descended at 36 h obviously. A dose-dependent relationship existed between LPS concentration and ICAM-1 expression. The abundance of ICAM-1 mRNA in cytoplasma of endothelial cells was upregulated significantly by LPS stimulation at 2 h and was maintained at a high level from 4 to 36 h. The upregulation of ICAM-1 protein and mRNA expression of LPS-induced HUVECs was markedly inhibited by SB203580 [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)imidazole], a highly specific inhibitor of p38 MAPK. Activity of p38 MAPK in HUVECs was increased at 15 min after LPS stimulation and reached the maximum at 60 min, then descended significantly. Activity of p38 MAPK was inhibited significantly by SB203580 in vitro. In vivo studies, administration of SB203580 (12.5 or 25 mg/kg, per ora) markedly reduced LPS-induced expression of ICAM-1 protein and mRNA of lung tissues of male BALB/c mice. These data highlight that the upregulation of ICAM-1 expression of LPS-induced endothelial cells in vitro and in vivo is mediated by p38 MAPK pathway at the level of gene transcription. The ICAM-1 expression of LPS-induced endothelial cells is characteristic of time dependence and dose dependence, and tolerates to chronic LPS stimulation. Inhibition of the p38 MAPK signal pathway may be used as an approach to attenuate ICAM-1 production in the treatment of septic shock.

Feedback Control of MKP-1 Expression by P38

THE MITOGEN-ACTIVATED PROTEIN KINASE p38 IS NECESSARY FOR INTERLEUKIN-1β-INDUCED MONOCYTE CHEMOATTRACTANT PROTEIN 1 EXPRESSION BY HUMAN MESANGIAL CELLS

Disruption of Transient Receptor Potential Melastatin 2 Attenuate Lipopolysaccharide-Induced Heme Oxygenase-1 Expression in Mouse Macrophages Through P38 Mitogen-Activated Protein Kinase (P5202)

Disruption of transient receptor potential melastatin 2 attenuate lipopolysaccharide-induced heme oxygenase-1 expression in mouse macrophages through p38 mitogen-activated protein kinase

P38 Mapk Contributes to Cd54 Expression and the Enhancement of Phagocytic Activity During Macrophage Development

Macrophage deletion of p38alpha partially impairs lipopolysaccharide-induced cellular activation.

MAPK and NF-κB Up-Regulated the Expression of Toll-Like Receptor 4 Induced by LPS in Pulmonary Micro-Vascular Endothelial Cell in Mouse

Inhibition of the p38 pathway upregulates macrophage JNK and ERK activities, and the ERK, JNK, and p38 MAP kinase pathways are reprogrammed during differentiation of the murine myeloid M1 cell line

MicroRNA-101 Targets MAPK Phosphatase-1 to Regulate the Activation of MAPKs in Macrophages

The p38 MAPK inhibitor SB203580 differentially modulates LPS-induced interleukin 6 expression in macrophages.

Activation of the Transcription Factor MEF2C by the MAP Kinase P38 in Inflammation.

Cross Talk between the Akt and p38α Pathways in Macrophages Downstream of Toll-Like Receptor Signaling

Control of IL-17 Receptor Signaling and Tissue Inflammation by the P38α–mkp-1 Signaling Axis in a Mouse Model of Multiple Sclerosis

The P38 MAPK Inhibitor JLU1124 Inhibits the Inflammatory Response Induced by Lipopolysaccharide Through the MAPK-NF-κB Pathway in RAW264.7 Macrophages.

p38 MAPK Activity Is Required to Prevent Hyperactivation of NLRP3 Inflammasome

Functional Roles of p38 Mitogen-Activated Protein Kinase in Macrophage-Mediated Inflammatory Responses

KINETICS OF MITOGEN-ACTIVATED PROTEIN KINASE FAMILY IN LIPOPOLYSACCHARIDE-STIMULATED MOUSE KUPFFER CELLS AND THEIR ROLE IN CYTOKINE PRODUCTION

Role of p38 MAPK in ICAM-1 expression of vascular endothelial cells induced by lipopolysaccharide.

MKP1 Regulates the Induction of Inflammatory Response by Pneumococcal Pneumolysin in Human Epithelial Cells

Distinct roles for p42/p44 and p38 mitogen-activated protein kinases in the induction of IL-2 by IL-1

Activation of p38 and determination of its activity.